Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain langauage summary to help more people find, understand and use it.
Read the Original
This page is a summary of: Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study, The Lancet Diabetes & Endocrinology, October 2018, Elsevier, DOI: 10.1016/s2213-8587(18)30233-x.
You can read the full text:
The following have contributed to this page